High-Dose Constraint-Induced Movement Therapy Beneficial for Cerebral Palsy
THURSDAY, Oct. 21, 2021 -- For children with hemiparetic cerebral palsy, high-dose constraint-induced movement therapy (CIMT) produces more consistent gains than usual customary treatment (UCT), according to a study published online Oct. 14 in Pediatrics.
Sharon Landesman Ramey, Ph.D., from the Fralin Biomedical Research Institute in Blacksburg, Virginia, and colleagues randomly assigned 118 2- to 8-year-olds with hemiparetic cerebral palsy to one of two doses and two constraint types of CIMT versus UCT. Participants were assessed at baseline, end of treatment, and six months after treatment.
The researchers found that when analyzing individual blinded outcomes, parent reports, and rank-order gains, findings varied in statistical significance. Regardless of constraint type, high-dose CIMT consistently produced a pattern of greatest short- and long-term gains (1.7 percent probability of occurring by chance alone) and significant gains at six months on visual motor integration and dissociated movement. High-dose CIMT produced significantly greater improvement than a moderate dose or UCT in O'Brien's rank-order analyses. In parent-reported functioning, there was significantly greater improvement for all CIMT groups versus UCT. Objective gains were revealed for children with UCT (e.g., 48 percent exceeded the smallest-detectable assisting hand assessment change compared with 71 percent for high-dose CIMT at the end of treatment).
"High doses of CIMT delivered in three-hour sessions five days per week for four weeks produced a consistent pattern of gains more than that of UCT on almost all blinded and parent-reported functional outcomes, although the findings are complex," the authors write.
© 2021 HealthDay. All rights reserved.
Posted October 2021
Read this next
THURSDAY, Dec. 2, 2021 -- Just one day after the first omicron case was reported in the United States, federal officials announced a second case on Thursday, this time in a...
THURSDAY, Dec. 2, 2021 -- Women are underrepresented in senior leadership throughout the U.S. health system, according to a research letter published online Nov. 29 in JAMA...
THURSDAY, Dec. 2, 2021 -- Cervical cancer incidence varies significantly between poor and wealthy New York City neighborhoods, according to a study published online Nov. 24 in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.